Your browser doesn't support javascript.
loading
Quantitative methods for optimizing patient outcomes in liver transplantation.
Al-Bahou, Raja; Bruner, Julia; Moore, Helen; Zarrinpar, Ali.
Afiliación
  • Al-Bahou R; Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
  • Bruner J; Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
  • Moore H; Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
  • Zarrinpar A; Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.
Liver Transpl ; 30(3): 311-320, 2024 03 01.
Article en En | MEDLINE | ID: mdl-38153309
ABSTRACT
Liver transplantation (LT) is a lifesaving yet complex intervention with considerable challenges impacting graft and patient outcomes. Despite best practices, 5-year graft survival is only 70%. Sophisticated quantitative techniques offer potential solutions by assimilating multifaceted data into insights exceeding human cognition. Optimizing donor-recipient matching and graft allocation presents additional intricacies, involving the integration of clinical and laboratory data to select the ideal donor and recipient pair. Allocation must balance physiological variables with geographical and logistical constraints and timing. Quantitative methods can integrate these complex factors to optimize graft utilization. Such methods can also aid in personalizing treatment regimens, drawing on both pretransplant and posttransplant data, possibly using continuous immunological monitoring to enable early detection of graft injury or infected states. Advanced analytics is thus poised to transform management in LT, maximizing graft and patient survival. In this review, we describe quantitative methods applied to organ transplantation, with a focus on LT. These include quantitative methods for (1) utilizing and allocating donor organs equitably and optimally, (2) improving surgical planning through preoperative imaging, (3) monitoring graft and immune status, (4) determining immunosuppressant doses, and (5) establishing and maintaining the health of graft and patient after LT.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Hígado Límite: Humans Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Hígado Límite: Humans Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos